Clinical Trial Detail

NCT ID NCT02332902
Title Everolimus for Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis1 CRAD001CUS232T
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements no
Sponsors The University of Texas Health Science Center, Houston
Indications
Therapies

Everolimus

Age Groups: adult

No variant requirements are available.